US: S&P 500, Nasdaq open at new highs on Covid-19 treatment hopes
DeeperDive is a beta AI feature. Refer to full articles for the facts.
[NEW YORK] The S&P 500 and Nasdaq opened at record levels on Monday after the US health regulator approved the emergency use of blood plasma in Covid-19 patients and on report the Trump administration may fast-track a vaccine candidate.
The S&P 500 opened higher by 20.93 points, or 0.62 per cent, at 3,418.09. The Nasdaq Composite gained 137.45 points, or 1.22 per cent, to 11,449.25 at the opening bell.
The Dow Jones Industrial Average rose 147.25 points, or 0.53 per cent, at the open to 28,077.58.
REUTERS
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
TRENDING NOW
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
Why where you park your joint venture matters: Lessons from a US$689 million shareholder dispute
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Singaporeans can now buy record amount of yen per Singdollar